A problem when preparing the devices for use can delay diagnosis or treatment, leading BD to update its instructions for use.

Bristol-Myers Squibb's financial position improved, it raised both its EPS guidance and revenue expectations, and Opdivo's ...

Despite two decades of clinical experience with Everolimus in transplant medicine, cancer patients continue to face ...

The Food and Drug Administration has identified a Class I recall of certain lots of BD esophagogastric balloon tamponade ...

It appears to be the generic version of a commonly prescribed drug used to alleviate symptoms experienced by 53 million ...